- Psychiatric Times Vol 20 No 10
- Volume 20
- Issue 10
Risperidone May Lower Risk of Falls
A study presented at the Eleventh International Congress of the International Psychogeriatric Association showed that risperidone 1 mg/day reduced the risk of falls in ambulatory patients with dementia. Data from 537 patients in a randomized, double-blind, placebo-controlled, 12-week, multicenter study of three doses of risperidone were included.
A study presented at the Eleventh International Congress of the International Psychogeriatric Association showed that risperidone (Risperdal) 1 mg/day reduced the risk of falls in ambulatory patients with dementia. Data from 537 patients in a randomized, double-blind, placebo-controlled, 12-week, multicenter study of three doses of risperidone (0.5 mg, 1 mg and 2 mg) were included.
During the trial, 109 patients (20.3%) fell. There was a statistically significantly lower fall rate for the patients taking 1 mg of risperidone than for patients taking placebo (12.7% versus 22.3%, p=0.04).
Behavioral symptoms were assessed with the Behavioral Pathology in Alzheimer's Disease (BEHAVE-AD) scale; only wandering was associated with an increased rate of falls. Eighty-three (21.1%) of the 393 patients with a baseline wandering score of >0 fell--EAD
Articles in this issue
almost 23 years ago
National Trauma: What Are the Consequences of War in the Middle East?almost 23 years ago
Research Fails to Link Talk Therapy With Heart Attack Survivalalmost 23 years ago
Genetic Components of Depression Identifiedalmost 23 years ago
Expressions of Social Anxiety in Asian-Americansalmost 23 years ago
Cultural Psychiatric Services: Past, Present and Futurealmost 23 years ago
Trauma and Violence in Childhood: A U.S. Perspectivealmost 23 years ago
Hispanics and Psychiatric Medications: An Overviewalmost 23 years ago
Are Assessment and Treatment Influenced by Ethnicity and Gender?almost 23 years ago
Cognitive Therapy's Faulty Schema
